Michael Frost

Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

Hope Northrup, Darcy A. Krueger, Hope Northrup et al. · Pediatric Neurology · 2013 · 1.5K citations · Full text

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Elizabeth A. Thiele, Eric D. Marsh, Jacqueline A. French et al. · The Lancet · 2018 · 868 citations

Placebo-controlled Phase 3, Neuropharmacology, Pharmacotherapy +4

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

John J. Bissler, J.C. Kingswood, Elżbieta Radzikowska et al. · The Lancet · 2013 · 863 citations

Tuberous Sclerosis Complex, Sporadic Lymphangioleiomyomatosis, Pathology +4

Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

Darcy A. Krueger, Hope Northrup, Hope Northrup et al. · Pediatric Neurology · 2013 · 834 citations · Full text

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

David Neal Franz, Steven Sparagana, E. Martina Bebin et al. · The Lancet · 2012 · 771 citations

Tuberous Sclerosis Complex, Neuro-oncology, Placebo-controlled Phase 3 +7